Baird Starts Eiger BioPharma (EIGR) at Outperform

January 28, 2019 4:09 PM
Baird analyst Madhu Kumar initiates coverage on Eiger BioPharma (NASDAQ: EIGR) with a Outperform rating and a price target of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot New Coverage New Coverage